What Researchers Did
Researchers retrospectively reviewed phone consultations regarding emergency hyperbaric oxygen therapy for carbon monoxide poisoning patients in Ankara, Turkey, over a one-year period.
What They Found
Out of 562 patients referred for hyperbaric oxygen therapy (HBOT) due to carbon monoxide poisoning, HBOT was recommended for 289 (51%) patients. Recommendations were made for 58% (n=194) of patients with carboxyhemoglobin levels ≥ 25%, 72% (n=163) with syncope, 67% (n=35) with ECG abnormalities, and 67% (n=14) of pregnant patients. Researchers also found that the duration from admission to consultation affected the decision to recommend HBOT, especially for severe cases.
What This Means for Canadian Patients
While this study is specific to Turkey, it highlights the critical importance of prompt referral for hyperbaric oxygen therapy in cases of severe carbon monoxide poisoning. Canadian patients experiencing carbon monoxide poisoning should seek immediate medical attention, and healthcare providers should consider timely consultation for specialized treatment when indicated.
Canadian Relevance
This study has no direct Canadian connection as it was conducted entirely in Ankara, Turkey.
Study Limitations
As a retrospective study based on phone consultations from a single region, the findings may not be generalizable to all populations or healthcare systems.